Literature DB >> 20412773

The Hippo pathway regulates Wnt/beta-catenin signaling.

Xaralabos Varelas1, Bryan W Miller, Richelle Sopko, Siyuan Song, Alex Gregorieff, Frederic A Fellouse, Rui Sakuma, Tony Pawson, Walter Hunziker, Helen McNeill, Jeffrey L Wrana, Liliana Attisano.   

Abstract

Several developmental pathways contribute to processes that regulate tissue growth and organ size. The Hippo pathway has emerged as one such critical regulator. However, how Hippo signaling is integrated with other pathways to coordinate these processes remains unclear. Here, we show that the Hippo pathway restricts Wnt/beta-Catenin signaling by promoting an interaction between TAZ and DVL in the cytoplasm. TAZ inhibits the CK1delta/epsilon-mediated phosphorylation of DVL, thereby inhibiting Wnt/beta-Catenin signaling. Abrogation of TAZ levels or Hippo signaling enhances Wnt3A-stimulated DVL phosphorylation, nuclear beta-Catenin, and Wnt target gene expression. Mice lacking Taz develop polycystic kidneys with enhanced cytoplasmic and nuclear beta-Catenin. Moreover, in Drosophila, Hippo signaling modulates Wg target gene expression. These results uncover a cytoplasmic function of TAZ in regulating Wnt signaling and highlight the role of the Hippo pathway in coordinating morphogenetic signaling with growth control. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412773     DOI: 10.1016/j.devcel.2010.03.007

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  247 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

3.  A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.

Authors:  Masamichi Imajo; Koichi Miyatake; Akira Iimura; Atsumu Miyamoto; Eisuke Nishida
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

4.  Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control.

Authors:  Yunyun Jin; Liang Dong; Yi Lu; Wenqing Wu; Qian Hao; Zhaocai Zhou; Jin Jiang; Yun Zhao; Lei Zhang
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

5.  The influence of skeletal muscle on the regulation of liver:body mass and liver regeneration.

Authors:  Jiansheng Huang; Martin Glauber; Zhaohua Qiu; Vered Gazit; Dennis J Dietzen; David A Rudnick
Journal:  Am J Pathol       Date:  2011-12-05       Impact factor: 4.307

6.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

7.  Yorkie Functions at the Cell Cortex to Promote Myosin Activation in a Non-transcriptional Manner.

Authors:  Jiajie Xu; Pamela J Vanderzalm; Michael Ludwig; Ting Su; Sherzod A Tokamov; Richard G Fehon
Journal:  Dev Cell       Date:  2018-07-19       Impact factor: 12.270

8.  The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.

Authors:  Steven G Chaulk; Victoria J Lattanzi; Samantha E Hiemer; Richard P Fahlman; Xaralabos Varelas
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.

Authors:  Ana Sebio; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

10.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.